Pharma Bio Services Statistics
Want to see PBSV full AI Analyst Report?
Pharma Bio Services (PBSV) Stock Statistics & Valuation Metrics
Total Valuation
Pharma Bio Services has a market cap or net worth of $9.20M. The enterprise value is $1.10M.
- Market Cap
- $9.20M
- Enterprise Value
- $1.10M
Share Statistics
Pharma Bio Services has 22,901,691 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,901,691
- Owned by Insiders
- 10.61%
- Owned by Institutions
- ―
Financial Efficiency
Pharma Bio Services’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -5.34%.
- Return on Equity (ROE)
- -0.01
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -5.34%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 163.66K
- Profits Per Employee
- -1,826.6
- Employee Count
- 55
- Asset Turnover
- 0.66
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pharma Bio Services is -1.39. Pharma Bio Services’s PEG ratio is 0.19.
- PE Ratio
- -1.39
- PS Ratio
- 1.21
- PB Ratio
- 0.00
- Price to FCF
- -0.04
- Price to Operating Cash Flow
- -0.04
- PEG Ratio
- 0.19
Income Statement
In the last 12 months, Pharma Bio Services had revenue of 9.00M and earned -100.46K in profits. Earnings per share was -0.00.
- Revenue
- 9.00M
- Gross Profit
- 2.91M
- Operating Income
- -637.66K
- Pretax Income
- -94.26K
- Net Income
- -100.46K
- EBITDA
- 134.81K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -304.53M and capital expenditures -6,470, giving a free cash flow of -304.53M billion.
- Operating Cash Flow
- -304.53M
- Free Cash Flow
- -304.53M
- Free Cash Flow per Share
- -13.30
Dividends & Yields
Pharma Bio Services pays an annual dividend of $0.08, resulting in a dividend yield of ―
- Dividend Per Share
- $0.08
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2659.47%
- Earnings Yield
- -121.85%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- -25.33%
- 50-Day Moving Average
- 0.47
- 200-Day Moving Average
- 0.51
- Relative Strength Index (RSI)
- 40.12
- Average Volume (3m)
- 6,324
Important Dates
Pharma Bio Services upcoming earnings date is Feb 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 14, 2026
- Next Earnings Date
- Feb 01, 2027
- Ex-Dividend Date
- Feb 27, 2026
Financial Position
Pharma Bio Services as a current ratio of 7.70, with Debt / Equity ratio of 0.24%
- Current Ratio
- 7.70
- Quick Ratio
- 7.70
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -24.85
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Pharma Bio Services has paid 6,203 in taxes.
- Income Tax
- 6,203
- Effective Tax Rate
- -0.07
Enterprise Valuation
Pharma Bio Services EV to EBITDA ratio is -409.45, with an EV/FCF ratio of -0.03.
- EV to Sales
- 1.05
- EV to EBITDA
- -409.45
- EV to Free Cash Flow
- -0.03
- EV to Operating Cash Flow
- -0.03
Balance Sheet
Pharma Bio Services has $8.58M in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.58M billion.
- Cash & Marketable Securities
- $8.58M
- Total Debt
- $0.00
- Net Cash
- $8.58M
- Net Cash Per Share
- $0.37
- Tangible Book Value Per Share
- $456.08
Margins
Gross margin is 32.32%, with operating margin of -1.63%, and net profit margin of -147.13%.
- Gross Margin
- 32.32%
- Operating Margin
- -1.63%
- Pretax Margin
- 2.84%
- Net Profit Margin
- -147.13%
- EBITDA Margin
- -0.26%
- EBIT Margin
- -1.63%
Analyst Forecast
The average price target for Pharma Bio Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.25%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 43
